相关实验视频

Updated: Jul 1, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

通过与HIF1A协调,CARM1驱动三阴性乳腺癌的进展

Dandan Feng^1,2, Jie Gao³, Ruiqiong Liu^3,4

¹Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

|March 13, 2024

概括

同活性剂相关的阿尔金因甲基转移酶1 (CARM1) 通过与HIF1A相互作用,驱动三阴性乳腺癌 (TNBC) 的进展. 自然化合物基酸抑制CARM1,为TNBC提供了潜在的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

已知同活性剂相关的阿金氨基甲基转移酶1 (CARM1) 促进雌激素受体α (ERα) 阳性乳腺癌的发展和转移.
在三阴性乳腺癌 (TNBC) 中CARM1的作用仍然在很大程度上未被描述,需要进一步调查.

研究的目的:

阐明TNBC中CARM1的功能和分子机制.
确定TNBC治疗的潜在治疗点和药物.

主要方法:

全基因组分析以确定CARM1招募的基因.
同免疫沉试验证实了CARM1和HIF1A的相互作用.
在体外研究中使用基酸作为CARM1抑制剂.

主要成果:

在TNBC中,CARM1显著促进了增殖,上皮-介质酶过渡和干性.
CARM1是由缺氧诱导因子-1亚单元α (HIF1A) 招募的,并准细胞周期和信号通路 (例如CDK4,β-Catenin,SIX1) 中的关键基因.
埃拉基酸通过抑制CDK4的表达,有效地抑制TNBC的增殖和入侵,显示出对CARM1.1的直接抑制作用.

结论:

通过与HIF1A的相互作用和瘤性途径的调节,CARM1在TNBC进展中发挥着关键作用.
埃拉基酸代表了潜在的TNBC治疗中CARM1的有前途的天然抑制剂.
了解TNBC中CARM1的分子基础为癌症药物开发提供了新的途径.

关键词:

在CARM1中,CARM1是CARM1.CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 这就是HIF1A.美国TNBC电视台埃拉基酸是一种酸.

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence

Published on: November 5, 2021

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...